子宫脱落细胞中检测到的突变作为子宫内膜癌诊断工具的评价
本研究纳入67例子宫内膜癌或子宫内膜不典型增生患者及31例良性对照,采用靶向二代测序分析组织、子宫脱落细胞和血浆配对样本,基于脱落细胞中常见突变基因开发20基因组合。该组合在脱落细胞与组织间突变谱一致性达99.2%,区分子宫内膜癌与良性对照的灵敏度为0.658、特异度为0.857、AUC为0.848;血浆ctDNA与组织突变一致性差。
要点
- 子宫脱落细胞与组织突变谱一致性达99.2%,可作为侵入性活检的替代样本。
- 20基因组合区分子宫内膜癌与良性对照的灵敏度0.658、特异度0.857、AUC 0.848。
- 血浆ctDNA与组织突变一致性差,在此场景下诊断效用有限。
核心结论
- 子宫脱落细胞中的20基因组合为子宫内膜癌提供了一种有前景的微创诊断工具,具有较高准确性和临床可行性。
- 该方法可能有助于早期发现并改善患者结局。
研究设计与样本
- 研究纳入67例患者,包括67例子宫内膜癌或子宫内膜不典型增生和31例良性对照,分为发现队列和验证队列。
- 采集组织、子宫脱落细胞和血浆配对样本,采用靶向二代测序进行分析。
主要发现
- 20基因组合在子宫脱落细胞与组织样本间的突变谱一致性为99.2%。
- 该组合区分子宫内膜癌与良性对照的灵敏度为0.658,特异度为0.857,AUC为0.848。
- 血浆ctDNA与组织突变一致性差,提示在此场景下诊断效用有限。
- 功能富集分析显示组合内基因参与腺体发育和凋亡相关通路。
关键数值与推荐
- 基于子宫脱落细胞中观察到的常见突变基因,开发了20基因组合用于识别提示子宫内膜癌的体细胞突变。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Endometrial cancer (EC) is a prevalent gynecological malignancy, yet current diagnostic methods are often invasive and inconvenient for patients. This study aimed to evaluate the potential of detecting somatic mutations in uterine exfoliation cells as a less-invasive diagnostic approach for EC. METHODS AND ANALYSIS: A total of 67 patients, including 67 cases of EC or endometrial atypical hyperplasia (EAH) and 31 benign controls, were enrolled across discovery and validation cohorts. Paired samples of tissue, uterine exfoliation cells, and plasma were collected and analyzed using targeted next-generation sequencing (NGS). Based on the frequently mutated genes observed in uterine exfoliation cells, a 20-gene panel was developed specifically to identify somatic mutations indicative of EC. RESULTS: The 20-gene panel demonstrated a high concordance (99.2%) between mutation profiles in uterine exfoliation cells and tissue samples, underscoring the reliability of exfoliation cells as a surrogate for invasive biopsies. Diagnostic performance analysis showed that the panel could distinguish EC from benign controls with a sensitivity of 0.658, specificity of 0.857, and an AUC of 0.848. Plasma ctDNA, however, exhibited poor concordance with tissue mutations, suggesting limited diagnostic utility in this context. Functional enrichment analysis indicated that the genes in the panel are involved in pathways related to gland development and apoptosis, highlighting their relevance to EC pathogenesis. CONCLUSIONS: The 20-gene panel in uterine exfoliation cells offers a promising less-invasive diagnostic tool for EC, with high accuracy and clinical feasibility. This approach could facilitate early detection and improve patient outcomes.
引用
- Yang W, Shen Y, Tian Y, et al. Evaluation of mutations detected in uterine exfoliated cells as a diagnostic tool for endometrial cancer. Gynecol Oncol. 2025. PMID: 40411967. doi:10.1016/j.ygyno.2025.05.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。